VeriMomchymotrypsin hamilelikte güvenli mi?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
Related ingredients
Frequently asked questions
- chymotrypsin hamilelikte güvenli mi?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
- chymotrypsin emzirirken güvenli mi?
- No data indicate chymotrypsin is a breastmilk-borne developmental hazard or that topical cosmetic use leads to systemic levels affecting lactation or the nursing infant. Human milk contains endogenous protease inhibitors (including antichymotrypsin), and regulatory reviews (food-enzyme safety) do not report lactation/transfer concerns. Respiratory sensitisation is noted in safety data sheets but does not constitute reproductive/lactation hazard evidence.
- chymotrypsin bebek cildi için güvenli mi?
- There is no evidence of infant-specific reproductive toxicity. As a protein enzyme, chymotrypsin is a large molecule with very limited dermal bioavailability for intact skin, so adult exposure score is 0; however, by your scoring rules infant skin exposure is increased by +1 because baby skin has a less mature barrier and higher surface-area-to-weight, so baby e = 1. No studies show adverse developmental effects from topical cosmetic use in infants.
- VeriMom chymotrypsin nasıl puanlıyor?
- VeriMom chymotrypsin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte chymotrypsin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.